Amy Elder, Ph.D.

Amy Elder brings over 25 years of experience in drug discovery collaborating in multi-functional teams across the areas of inflammation, oncology and CNS. In her role as Director of Chemistry, Amy Elder oversees drug discovery and medicinal chemistry activities for Quiver’s small molecule and ASO projects. She also assists in the project management and oversight of CMC activities and toxicology studies.  Prior to joining Quiver Bioscience, Amy assisted in establishing the chemistry department at Galenea. She held scientific positions of increasing responsibility at Millennium Pharmaceuticals and Pfizer. Amy received a Ph.D. in synthetic organic chemistry from the University of Wisconsin, Madison.